Skip to main content
BMA
NYSE Finance

Macro Bank Reports Mixed Q4 2025 Results with Significant Deterioration in Asset Quality

Analysis by Wiseek.ai
Sentiment info
Negative
Importance info
8
Price
$89.38
Mkt Cap
$6.038B
52W Low
$38.3
52W High
$106.15
Market data snapshot near publication time

summarizeSummary

Macro Bank reported a recovery in Q4 2025 net income but a sharp rise in non-performing loans, alongside a new $400M bond issuance and ongoing dividend payments.


check_boxKey Events

  • 4Q25 Net Income Recovery

    The Bank reported net income of Ps. 100.1 billion in 4Q25, recovering from a loss in 3Q25, but still 26% lower than 4Q24. Full-year 2025 net income was Ps. 290.7 billion.

  • Significant Deterioration in Asset Quality

    The non-performing to total financing ratio increased substantially to 3.87% in 4Q25, up from 3.19% in 3Q25 and 1.28% in 4Q24, signaling rising credit risk.

  • Cost Control Measures Implemented

    During FY2025, Banco Macro reduced its branch network by 75 branches and its headcount by 514 employees, contributing to an improved efficiency ratio of 38.7% in 4Q25.

  • Strong Capital Position Maintained

    The bank reported an excess capital of Ps. 3.61 trillion and a Capital Adequacy Ratio of 30.6%, indicating robust solvency.


auto_awesomeAnalysis

Macro Bank's fourth-quarter 2025 earnings report reveals a mixed financial picture. While net income recovered from a loss in the prior quarter, it remained 26% lower year-over-year. The most concerning aspect is the significant deterioration in asset quality, with the non-performing loan ratio jumping from 1.28% in 4Q24 to 3.87% in 4Q25, indicating increased credit risk. The bank also announced a new USD 400 million bond issuance for refinancing and provided an update on its substantial cash dividend payments. Investors should closely monitor the trend in asset quality and its potential impact on future profitability, despite the bank's strong capital position and cost-cutting efforts.

At the time of this filing, BMA was trading at $89.38 on NYSE in the Finance sector, with a market capitalization of approximately $6B. The 52-week trading range was $38.30 to $106.15. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

descriptionView Main SEC Filing

show_chartPrice Chart

Share this article

Copied!

feed BMA - Latest Insights

BMA
Apr 20, 2026, 3:48 PM EDT
Filing Type: 20-F
Importance Score:
9
BMA
Apr 08, 2026, 11:42 AM EDT
Filing Type: 6-K
Importance Score:
7
BMA
Mar 20, 2026, 4:23 PM EDT
Filing Type: 6-K
Importance Score:
8
BMA
Mar 20, 2026, 9:10 AM EDT
Filing Type: 6-K
Importance Score:
7
BMA
Mar 09, 2026, 4:14 PM EDT
Filing Type: 6-K
Importance Score:
7
BMA
Feb 25, 2026, 4:51 PM EST
Filing Type: 6-K
Importance Score:
8
BMA
Feb 25, 2026, 4:37 PM EST
Filing Type: 6-K
Importance Score:
8
BMA
Jan 22, 2026, 7:36 AM EST
Filing Type: 6-K
Importance Score:
8